Assured Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Assured Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,181	Closed	-$5.86M	–	143
2019 Q1	$5.86M	Buy	+19,181	New	+$5.18M	0.07%	131
2018 Q2	–	Sell	-8,689	Closed	-$2.17M	–	1173
2018 Q1	$2.17M	Sell	8,689 -2,102	-19%	-$535K	0.05%	337
2017 Q4	$2.58M	Buy	+10,791	New	+$2.61M	0.05%	333
2017 Q3	–	Sell	-960	Closed	-$217K	–	604
2017 Q2	$217K	Sell	960 -4,113	-81%	-$896K	﹤0.01%	521
2017 Q1	$1.01M	Buy	+5,073	New	+$977K	0.02%	298

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Assured Investment Management's BIO Position: Q2 2019 in Review

Assured Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2019, closing a stake of 19,181 shares — an estimated $5.86M sold.

Assured Investment Management first reported a position in BIO in Q1 2017 and held it in 5 quarters. The position peaked at $5.86M in Q1 2019. 330 funds tracked by Wall St. Rank hold BIO as of Q2 2019.

Assured Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 19,181 Bio-Rad Laboratories Class A shares in Q2 2019, an estimated $5.86M.
Assured Investment Management first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and held it in 5 quarters.
Assured Investment Management's Bio-Rad Laboratories Class A position peaked at $5.86M in Q1 2019.
330 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.